Previous Article | Next Article ![]()
Journal of Clinical Microbiology, March 2008, p. 1118-1122, Vol. 46, No. 3
0095-1137/08/$08.00+0 doi:10.1128/JCM.01309-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Centre for Antimicrobial Resistance, Calgary Health Region, Calgary, Alberta, Calgary Laboratory Services, Calgary, Alberta, and University of Calgary, Calgary, Alberta, Canada,1 Departments of Pathology and Laboratory Medicine,2 Microbiology and Infectious Diseases,3 Medicine,4 Institute of Infection, Immunity and Inflammation, University of Calgary, Calgary, Alberta, Canada,5 Calgary Laboratory Services, Calgary, Alberta, Canada6
Received 29 June 2007/ Returned for modification 26 September 2007/ Accepted 19 December 2007
|
|
|---|
|
|
|---|
(This work was presented in part at the 107th General Meeting of American Society for Microbiology, 21-25 May, 2007, Toronto, Canada [abstract C-238].)
Sequence alignment and primer design.
Primers for 16S rRNA (Stapy756-F and Staph750-R) (15), thermostable nuclease (nuc) (Nuc-1 and Nuc-2) (15), mecA (mecA147-F and mecA147-R) (14), and PVL genes lukS-PV/lukF-PV (Luk-PV-1 and Luk-PV-2) (7) were as previously described. New sets of primers for strains USA300 and USA400 and for prophage
Sa2usa/
Sa2mw were designed based on comprehensive analysis and alignment of individual Staphylococcus sp. genomes currently available in the GenBank database. Gene targets for each primer pair are as follows: USA300 strain primers arcA-F (5'-GCAGCAGAATCTATTACTGAGCC-3') and arcA-R (5'-TGCTAACTTTTCTATTGCTTGAGC-3') target the arcA gene on the arginine catabolic mobile element (ACME); USA400 strain primers MW756-F (5'-TGGTTAGCTATGAATGTAGTTGC-3') and MW756-R (5'-GTCCATCCTCTGTAAATTTTGC-3') target the gene locus MW0756 on
Sa3 of strain MW2; and
Sa2mw/
Sa2usa prophage primers phi-int-F4 (5'-CAAATTTTGAAAACTTTACGC-3') and phi-int-R4 (5'-TCCAGGATTAAAAGAAGCG-3') target the MW1409 gene locus of the USA400 MW2 strain.
Development of an M-PCR assay for typing MRSA isolates and distinguishing USA300 and USA400 strains. The assay specifically involved targeting the Staphylococcus genus-specific 16S rRNA gene sequence (serving to distinguish Staphylococcus from other bacteria and acting as an internal PCR control), the S. aureus-specific nuc gene, the methicillin resistance determinant mecA, the PVL genes, the phage marker MW1409, the USA400 genomic island gene locus (MW0756), and the USA300 ACME cassette gene (arcA). Amplification in a single M-PCR produced distinct bands corresponding to molecular sizes of 147, 220, 279, 372, 433, 513, and 756 bp for mecA, MW1409, nuc, MW0756, PVL, arcA, and 16S rRNA, respectively (Fig. 1).
![]() View larger version (38K): [in a new window] |
FIG. 1. Novel multiplex PCR assay identifying USA300 and USA400 community-associated MRSA strains, detecting PVL and mecA genes, and simultaneously discriminating S. aureus from CoNS. The optimized M-PCR was performed as follows: 4.65 µl of template DNA was prepared as previously described (15) in a 25-µl final reaction volume containing 0.30, 0.3, 0.4, 0.32, 0.16, 1.17, and 0.16 µM for each of the 16S rRNA, arcA, lukS-PV/lukF-PV, MW0756, nuc, MW1409, and mecA primers, respectively, with the thermocycling conditions set at 94°C for 4 min followed by 10 cycles of 94°C for 30 s, 60°C for 30 s, 72°C for 45 s and another 25 cycles of 94°C for 30 s, 52°C for 30 s, and 72°C for 45 s. The PCR amplicons were visualized using a UV light box after electrophoresis on a 2% agarose gel containing 0.5 µg/ml ethidium bromide. Lane 1, strain ATCC 29213 (PVL– MSSA); lane 2, strain ATCC 49775 (PVL+ MSSA); lane 3, Canadian epidemic MRSA control strain CMRSA2 (PVL– non-USA300 and non-USA400 MRSA); lane 4, strain C1538 (PVL+ non-USA300 and non-USA400 MRSA); lane 5, strain C2901 (PVL– USA400); lane 6, Canadian epidemic CA-MRSA USA400 control strain CMRSA7 (PVL+ USA400); lane 7, Canadian epidemic CA-MRSA USA300 control strain CMRSA10 (PVL+ USA300); lane 8, strain CNS99-PF5 (PVL– and arcA– MS-CoNS); lane 9, strain CNS99-PF7 (PVL– but arcA+ MS-CoNS); lane 10, strain CNS99-PF6 (PVL– and arcA– MR-CoNS); lane 11, strain CNS99-PF8 (PVL– but arcA+ MR-CoNS); lanes M, 1 kb Plus DNA ladder (Invitrogen). Refer to Table 1 for details of each strain.
|
Sa2mw/
Sa2usa phages, with a resultant 100% concordance to genotypic features in all these control strains (Table 1). There were seven PVL+ MRSA and nine PVL+ MSSA strains, belonging to non-USA300/non-USA400 strains with well-diversified genomic backgrounds, and all were positive for the PVL genes but negative for the
Sa2mw/
Sa2usa phage marker, suggesting that PVL genes in these strains may be carried by phages/plasmids other than
Sa2mw/
Sa2usa. More interestingly, there were two strains (with non-USA300/non-USA400 PFGE profiles), one a PVL– MRSA strain (CMRSA5) and one a PVL+ MSSA strain (SAF516), that were positive for the phage marker. Since this primer pair is a marker for the PVL-bearing phage
Sa2mw/
Sa2usa in USA400/USA300, this result suggests that variations of these particular phages can also be present in S. aureus strains other than USA300 and USA400 with or without the PVL genes. Further studies are required to better understand this observation. |
View this table: [in a new window] |
TABLE 1. Molecular and genotypic features of Staphylococcus aureus and CoNS control strainsa
|
Sa2mw/
Sa2usa gene. Among 439 CoNS isolates tested, there was a 100% concordance with phenotypic susceptibility to methicillin, with 214 of the isolates being methicillin-susceptible CoNS (MS-CoNS) and 225 being methicillin-resistant CoNS (MR-CoNS). Of the MS-CoNS isolates, 75 (35.0%) of them were positive for arcA, while 93 (41.3%) of the MR-CoNS isolates were arcA positive. None of the CoNS isolates tested carried PVL,
Sa2mw/usa phage, or USA400 marker MW0756 gene loci.
Our assay is capable not only of (i) accurately identifying and differentiating USA300 and USA400 strains but also of simultaneously detecting (ii) mecA to discriminate MRSA from MSSA and (iii) 16S rRNA and nuc to discriminate S. aureus from CoNS and of detecting (iv) PVL genes and a
Sa2mw/usa-specific gene to determine whether the isolates/strains carry PVL genes and whether the PVL genes are carried by the
Sa2mw/
Sa2usa phage or other prophages in the population. Our M-PCR assay may also facilitate monitoring of the dynamic exchanges or evolution of genes among strains of MRSA, MSSA, and CoNS. This assay is based on the concept of certain strains carrying unique/specific genes/phages. However, since movement of these genes, phages, and other genetic elements is dynamic, the definition of a strain, as determined by the use of our assay for detection of gene targets uniquely present in individual CA-MRSA strains, may require reconsideration over time.
Published ahead of print on 26 December 2007. ![]()
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»